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ABSTRACT 
It is common to find Competitive Intelligence activities within the high-tech enterprises in particular in the pharmaceutical 
industry. These companies not only use the process of Competitive Intelligence to act against competitors, traditional aim 
of the Competitive Intelligence. It is increasingly used to enhance cooperation. The Cycle of Competitive Intelligence (Cl) 
is used both as to extract offensive and defensive intelligence as cooperative intelligence. The paper presents the results 
of a sample study of 186 Spanish pharmaceutical companies that were asked about the purpose of cooperation in their 
Competitive Intelligence activities. The results confirm that these are used in the development of business relationships, 
search for partners, joint research, etc. and that companies bet on these relationships for the future within the Competitive 
Intelligence. 
Keywords: Cycle of Competitive Intelligence; Competitive Intelligence Process; Knowledge Management; Pharmaceutical 
Sector; Cooperation. 
1. INTRODUCTION 
Competitive intelligence (Cl) is one of the most useful 
tools for strategic analysis because it provides, analyses 
and distributes information, the knowledge and intelligence 
throughout the organization. 
In the last years there has been a rising in the so-called 
Competitive Intelligence in the field of Information and 
corporative knowledge that has not been accompanied by 
the same interest in the theoretical basis (Palop et Vicente, 
1999; Escorsa et Maspons, 2001; Hidalgo et al., 2002; 
Postigo, 2001, Tena etComai, 2001). Several newtrends have 
emerged in literature that have brought closer, with a better 
or worse choice, the Competitive Intelligence theoretical 
frame. But there is still so much to study about how the Cl 
process is and why it works, what types of intelligence we 
can detect inside the organization, who is the responsible 
person in charge to perform this work, which ones are the 
conceptual terms that are used in the different academic 
papers, the results from the creation and administration of 
the knowledge and the information that is used, as well as 
the corporation's intelectual capital, etc. 
The importance given to Cl has been based on offensive 
and defensive activities implemented in the company. 
However, some authors have opened another research line 
that creates tools to make decisions in other directions. 
Thus, sometimes the company launches its Cl to research 
the environment and competition in particular with the aim 
to enhance internal improvements or collaborations with 
companies (e.g. for open innovation lines). 
The Medical College Organisation report (OMC) on the 
pharmaceutical sector (OMC, 2014) that some actions 
are recommended to increase the competitiveness of the 
sector. The OMC says that it would be reasonable to expect 
a process of concentraron and restructuring that promotes 
partnerships, joint ventures or mergers to créate solvent 
and innovative pharmaceutical companies. It is noteworthy 
that the research model of the pharmaceutical industry 
continúes to evolve over the last decade, from the classic 
pattern of R&D to prototype called R&C (cooperation and/ 
or collaboration). 
In this sense, the goal of the study is to analyse the 
behaviour of pharmaceutical companies integrated in the 
Farmaindustria association with the possibility to improve 
the cooperation amongst them by using Cl cycle activities. 
Five phases are suggested in the process of Cl generation 
to study in each of them the importance of cooperation. 
The aim is to determine whether cooperation is a purpose 
in using the Cl in a company and, if so, we can expect Cl 
processes to evolve and enhance the relationship networks 
between companies in the sector. 
In this respect, this paper contribution is in the direction 
marked by The Green Book on Innovation of the European 
Commission, where we are urged to accentuate the efforts 
made to investígate the national practices in the European 
Union of different methods and specific processes of 
collection, management, treatment and classification of 
information that is used in the Competitive Intelligence. 
2. THEORETICAL CONSIDERATIONS 
The Strategic and Competitive Intelligence Professionals 
(SCIP) describes competitive intelligence as "the process 
of gathering ethically, analysis and disseminate reliable, 
relevant, specific intelligence, timely, foresighted and 
actionable, regarding the implications of the business 
environment the competitors and the organization itself " 
(SCIP, 1999). 
However, there are many Cl definitions provided by 
different authors remarking the strategic aspect and 
the variety of targets with their activities (Cohén, 1997; 
McGonagle, 1998; Bernhardt, 1994; Hockman, 1999). In 
this way, as Cohén (1997) et McGogagle (1998) say, the 
Competitive Intelligence is a combination of methods, 
ethic and legal processes, abilities and behaviours of the 
competence to obtain a competitive and sustainable 
advantage to this company. 
Bernhardt (1994) defines Competitive Intelligences as 
"an analytic process that transforms disintegrated data from 
competitors, industry and market, putting them together 
to get knowledge that is usefull to the strategic planning, 
related with abilities, intentions, performance and position 
of these competitors". 
The information provided to the organization by the Cl, 
properly treated, generates intelligence on which to base 
strategic planning and decisión making and with an impact 
on organizational performance (Prescot, 1999; Herring, 
1999; Ortoll et al., 2010; Antia et Hesford, 2007; Tena et 
Comai, 2003). 
Knowledge is the basis in which these intangible 
resources exist in the Corporation and it owns some qualities 
that complícate its imitation and transference (Grant, 1996). 
This issue will give a competitive advantage in the market to 
the company that will be able to manage in an efficient way 
this knowledge. In order to do so, it is necessary to consider 
its management as a dynamic process where identification, 
storage, formation and recycling of the above mentioned 
knowledge in the organization take part. 
From this basis, it is easy to understand the importance 
of Competitive Intelligence. It is shown as a part of this 
strategy, as a systematized activity that gathers information 
about the environment and introduces it in the organization 
to genérate knowledge, and in order to be a part in 
the decisión making process. At the same time that Cl 
generates knowledge, it uses the existing knowledge in the 
organization and modifies it, complementing and improving 
it. The modification of that organizational knowledge basis 
will be available in the core of the company for future needs. 
There is no current data in literature on the number 
of companies carrying out competitive intelligence as a 
systemic process. Studies in Spain (Postigo, 2001; Infoact, 
2001; Cetisme, 2003; Tena et Comai, 2003) cannot detail the 
spread of practice in companies due to the heterogeneity of 
the analysed organizations. 
2.1. Cl Cicle 
Despite the virtual unanimity on the scientific method 
being the precedent of the intelligence cycle (Vignettes, 
2010), we can say that there has never been agreement 
on the number, ñame and specific content of the phases 
comprising it. However, when analysing the mentioned 
characteristics and phases, we find in literature some 
common trends in different authors and communities as 
well as important differences between them. 
It is noteworthy that the positions are not contradictory 
but complementary (Bernhardt, 1994; Ortoll et al., 2010; 
Prescott, 1999; Choo, 2002; Lesea, 2006; Arroyo, 2005; 
Martinet et Marti, 1995; Escorsa et Maspons, 2001; Ashton 
et Stacey, 1995). Competitive intelligence is a dynamic 
strategic tool for the survival and growth of the present 
companies. From the theoretical studies, different phases 
have been proposed. The need of some logical phases lays in 
the interest of formalizing and systematizing the Cl process 
(Bernhardt, 1999). 
On this basis, the proposed Cl is formed by five phases 
(Figure 1): Planning of resources and activities; Collection 
and validation of ¡nformation; Analysis and dissemination 
of intelligence; Using the results; and Evaluation of process 
performance. 
We will briefly revise these phases: 
Figure 1. Competitive Intelligence Cycle of five phases 
Souce: The author own 
2.1.1. Planning of resources and activities 
Companies need to plan the Cl activities bearing in mind 
the final aim. Sometimes planning needs legal ¡nformation, 
tax rate, etc. Others, it needs ¡nformation from competitors 
to know what they are and their activities in the sector. 
In other occasions the priority is in the ¡nformation on 
market changes, produets and processes, etc. 
2.1.2. Collection and validation of ¡nformation 
At this stage of Cl companies evalúate where and under 
what conditions gather the necessary ¡nformation to fulfill 
their need. 
Therefore, it is mandatory to know the sources of such 
¡nformation (internal, external, prívate, public, structured, 
unstructured, etc.) It is also important to know the existence 
of controls, validation and verification of sources and 
¡nformation. 
2.1.3. Analysis and dissemination of intelligence 
At this stage of the process the tools used for data analysis, 
analysis and control ofboth the ¡nformation storage and the 
needed and generated, are of great importance. 
The different ways to broadeast or disseminate the 
intelligence generated in the organization can be carried 
out by taking into account individuáis or specific group 
departments (marketing, R&D&I, sales network, general 
management, etc.), users subsidiarles or from within the 
organization. 
It is also important to know the kind of dissemination 
that is carried out from the media's point of view (meetings, 
intranet or other). 
2.1.4. Using the results 
At this stage itis important toremark the activities focused 
to sort out problems and analyse whether the company is 
aware that the Cl has managed to solve risky situations in 
departments, subsidiarles, projeets, etc., and if it is expected 
that the results of the Cl serve to sort out different issues. 
2.1.5. Evaluation of process performance 
Companies should evalúate the results of the Cl cycle to 
enable process improvement and the necessary adjustments 
on the planned targets. 
It is necessary to evalúate activities flexibility, Cl user's 
satisfaction, improvements in the strategic áreas of the 
organization, etc. 
2.2. Purpose of Cooperation and Cl 
Information has a first magnitude strategic dimensión, 
either as active means of defense-knowing to prevent- or 
reactive -knowing to attack (Kahn, 2001). 
However, authors like Ortoll et al. (2010) confirm that 
the impact of social networks on both information sources 
and the efficiency of the whole process of competitive 
intelligence is significant. Thus, several authors have 
explored the importance of social networks in the process 
of competitive intelligence (Palop et Vicente, 1999; Escorsa 
et Maspons 2001; Trim, 2004; Michaeli, 2006), especially the 
importance of networks as sources of information for their 
members. Some researchers also relate the involvement 
of network structure on the efficiency of the process of Cl 
(Jaworskieto/,,2002). 
This job has planned a model that, just as others (Tena 
et Comai, 2001; Hussey et Jenster, 1999) takes into account 
the purpose of the Cl in the company. Two objectives are 
proposed in the activities of the Cl cycle. The company may 
determine that part or the whole of the Cl activity pursue 
the so called competitor intelligence (for defensive and 
offensive actions) and can determine how much of the Cl is 
intended for a cooperative intelligence. 
There is wide reference of competitor intelligence in 
literature due to the Cl's own nature, but it is harder to 
find evidence of the second, competitive intelligence for 
cooperation, partner search, agreements, etc. However, 
activities taking place in the Cl cycle can be used in a broad 
spectrum of fundamental issues for the development of a 
partnership (finance, marketing, R&D&I, etc.). 
3. METHOD 
This job applies a descriptive and explanatory method 
based on a questionnaire addressed to analyse the Cl 
phases, the targets pursued by the company and the impact 
on some business results. 
In this paper, we expect to adhere ourselves to one 
sector that is a pioneer in putting in practice Cl and that 
is developing the activities in the Competitive Intelligence 
Cycle, the Pharmaceutical Industry. In order to do so, a 
sample of the sector the National Business Association of 
the Pharmaceutical Industry (Farmaindustria ) established in 
Spain was taken to carry out this study. The group has the 
vast majority of pharmaceutical laboratories (186 members 
representing 84% of the prescription market and 42% of the 
holders of marketing authorizations for medicines). 
In the report made by Spanish Medical College 
Organization (OMC) in 2014 about the pharmaceutical 
sector, data that shows the frame for intervention of this 
industry is found. In this sense, in the last 40 years has been 
the sector with the fastest growth in Europe and in the 
United States, portraying today a business volume bigger 
than 3.5 billion dollars (EFPIA, 2011). 
The final questionnaire was obtained after several 
meetings with industry experts (managers, laboratory 
owners) área doctors of the company organisation and the 
sub-department of Farmaindustria. After validating the 
questionnaire it was sent to all partners in Farmaindustria 
guaranteeing the confidentiality of responses. 
It is important to remark the existing difficulty to 
draw information from these companies. You have to go 
through many different filters in order that pharmaceutical 
companies consider it innocuous to answer questions on 
the information they use. In most cases legal departments 
should approve the questionnaires and this may take weeks. 
The five Cl phases compiling the theory bases of the 
different authors were laid out. At each stage of the Cl cycle, 
laboratories were asked for different aspects of the interest 
in cooperation. With the answers to the questionnaire a 
descriptive analysis of the use of Cl for cooperation activities 
and expectations of pharmaceutical companies was carried 
out. 
4. RESULTS 
The results are divided according to the five phases of the 
Cl cycle (Table 1). In the planning phase 65 % of companies 
stated that they commonly use Cl consulting when 
cooperation activities are intended. Given the competitive 
nature of the Cl it seems that, as stated by Tena et Comai 
(2001), the cooperative intelligence has significant purposes 
for the process. 
During the second stage, information collection phase, 
over 50% of companies answer that they commonly use 
sources of information from their partners in research 
projects. That shows the level of relationship that comes 
to have companies so protective towards the security of 
their information when it happens to investígate with other 
companies. There are also a high percentage of companies 
using information from other subsidiarles of the group at 
times or on many occasions. Bearing in mind they were asked 
in the context of Cl, it is noteworthy that the percentages of 
consultation between partners and between subsidiarles of 
the same group are not far. 
In the third phase of the Cl cycle, companies declared that 
40% send relevant information to the project partners, while 
only 6.4 % do so to their own subsidiarles. It is remarkable 
the importance given to the management of information 
between partners when having a common project. It should 
be noted that they were not asked for a specific project, but 
for their usual performance in the context of Cl. 
The fourth phase, referring to the use of the results, it is 
noted that 66% of cases f requently use the reports generated 
in Cl in other companies of the same group, but not a regular 
system as only 10% do so. In both situatíons described 
usage decreases when asked for external companies in the 
same group. Using Cl reports between project partners is 
also important (40% of respondents), whilst almost 39% 
never or almost never used them. 
The last phase, performance evaluation, reveáis that 
pharmaceutical companies consider that Cl encourages 
collaboration with other organizations (over 60% agree or 
strongly agree with this). Regarding the detection of new 
financial partners approximately 30% said that the Cl was 
not relevant or had minor importance, but 50% said it was 
quite or very important. 
Finally, as to the intention to increase Cl resources, 
willingness was shown to increase resources in the 
pharmaceutical sector, regardless the current economic 
situation. 
Table 1. Summary of main results 
The five 
phases 
1. Planningof 
resources and 
activities 
- 65 %of companies stated that they commonly use Cl 
Consulting when cooperation activities are intended. 
- Given the competitive nature of the Cl it seems that, 
as stated by Tena et Comai (2001), the cooperative 
intelligence has significant purposes for the process. 
2. Collection 
and 
validation of 
information 
- Over 50 % of companies answer that they 
commonly use sources of information from their 
partners in research projects which shows the level 
of relationship that come to have companies so 
protective towards the security of their information 
when it comes to investígate with other companies. 
- There are also a high percentage of companies using 
information from other subsidiarles of the group at 
times or on many occasions. 
- Bearingin mind they wereasked in thecontext of Cl, 
it is noteworthy that the percentages of consultation 
between partners and between subsidiarles of the 
same group are not far. 
3. Analysis 
and 
dissemination 
of intelligence 
- The companies declared that 40% send relevant 
information to the project partners, while only 6.4 % 
do so to their own subsidiarles. 
- It is remarkable the importance given to the 
management of information between partners when 
having a common project. It should be noted that 
they were not asked for a specific project, but for 
their usual performance in the context of Cl. 
4. Usingthe 
results 
- It is noted that 66 % of cases frequently use the 
reports generated in Cl in other companies of the 
same group, but not a regular system as only 10% do 
so. 
- In both situatíons described usage decreases when 
asked for external companies in the same group. 
Using Cl reports between project partners is also 
important (40 % of respondents), whilst almost 39% 
never or almost never used them. 
5. Evaluation 
ofprocess 
performance 
- The pharmaceutical companies consider that Cl 
encourages collaboration with other organisatíons 
(over 60 % agree or strongly agree with this). 
- Regarding the detection of new financial partners 
approximately 30% said that the Cl was not relevant 
or had minor importance, but 50% said it was quite or 
very important. 
Souce: The author own 
5. CONCLUSIONS 
During the study, it is confirmed the use of Cl for 
cooperation in each stage of the Cl cycle, that is, the use of 
Cl not only it looks for to defend or to attack. 
Farmaindustria's pharmaceutical companies show 
that they commonly use other companies' sources of 
information, they share the knowledge gained in the Cl 
process with project partners and consider that the Cl 
encourages collaboration with other entities. It should be 
noted that they were not asked for a specific project but by 
the usual action for cooperation in the framework of Cl. 
The main conclusión is that most pharmaceutical 
companies are committed to sharing knowledge generated 
during the Cl process with other companies, subsidiarles 
or partners despite such tight controls imposed in the 
sector when it comes to extracting information in their 
organizations. 
In general, there was a willingness to increase the 
resources invested in Cl in the pharmaceutical sector. It 
seems that if we bet for cooperation, companies will find in 
the intelligence process a valuable ally to advance towards 
their research objectives and growth. 
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